The iShares Biotechnology ETF is the default large-cap vehicle for the sector. It is market-cap weighted, which concentrates the fund in cash-generative incumbents rather than spreading capital across clinical-stage names.
Chinese stocks have spent the last five years really testing the patience of even the most hardcore contrarians. Between the property sector struggles, the crackdown on tech platforms, and the constant friction over chip exports and tariffs, valuations have been pushed down across the board.
We see people asking all these questions to ChatGPT and Claude, but those services are not optimized. Astor is built on a multi-agent architecture that draws on Anthropic models.
AI agents generate so much software, so fast, it's nearly impossible for humans to carefully review it all. Cloudsmith has the scale and the broad view across the open-source ecosystem to protect enterprises against the new kinds of threats that AI-driven development introduces.
Japanet Holdings has quadrupled its venture capital fund to $200 million after early investments through Pegasus Tech Ventures in Anthropic, xAI, SpaceX, and OpenAI generated extraordinary paper returns.
